Checked November 14, 2026 · Published by Ozari Health
Telehealth brands send compounded semaglutide and tirzepatide prescriptions to a small set of pharmacies. This directory lists the ones patients search for most, with each pharmacy's type, location, phone number, FDA record and the brands that name it on their own sites.
Every fact links to its source: the pharmacy's own website, FDA's public records, or a brand's own page. None of these pharmacies fill Ozari prescriptions. Ozari's pharmacies are listed on Pharmacy Standards.
| Pharmacy | Type | Based in | FDA actions listed | Brands that name it |
|---|---|---|---|---|
| Belmar Pharmacy | 503A and 503B | Golden, CO | 5 (latest July 16, 2025) | None found |
| Empower Pharmacy | 503A and 503B | Houston, TX | 8 (latest September 18, 2026) | Lavender Sky Health, Ivím Health |
| Olympia Pharmacy | 503A and 503B | Orlando, FL | 5 (latest September 3, 2026) | Ivím Health |
| Red Rock Pharmacy | 503A | Springville, UT | 1 (latest July 31, 2026) | Lavender Sky Health, Embody (Joinem) |
| Revive Rx | 503A | Houston, TX | 6 (latest March 27, 2026) | Lavender Sky Health |
| Southend Pharmacy | 503A | Houston, TX | None listed | Lavender Sky Health, Ondra Health |
| Strive Pharmacy | 503A, with a new 503B | Gilbert, AZ | 1 (latest September 8, 2023) | Lavender Sky Health |
Ozari names every pharmacy that fills its prescriptions, with its type, address, credentials and contact details.
A 503A pharmacy compounds patient-specific prescriptions and is licensed by state boards of pharmacy. A 503B outsourcing facility registers with FDA, can compound in larger batches, and FDA inspects it against federal manufacturing standards. Neither makes FDA-approved drugs when it compounds.
Ask the telehealth company before you pay, and read the vial label, which names the dispensing pharmacy. Some brands list their pharmacies on their websites; this directory links to those pages.
A Form 483 lists conditions an FDA investigator observed during an inspection. It is not a final agency finding, and the pharmacy can respond. A warning letter is FDA's formal notice that it found significant violations.
Ozari publishes its pharmacies on its Pharmacy Standards page, with each pharmacy's type, address and credentials. The pharmacies in this directory do not fill Ozari prescriptions.
Compounded semaglutide and tirzepatide are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality. The pharmacies listed are not affiliated with Ozari Health. FDA records come from FDA's compounding inspections and actions list. To report an error, email press@ozarihealth.com.
Join thousands of patients who have already transformed their lives with science-backed weight loss treatment.
Get Started — It's Free